title: Fixed-dose combination therapy for the prevention of cardiovascular disease.
abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of fixed-dose combination therapy on optimising CVD risk factors and reducing CVD fatal and non-fatal events for both primary and secondary prevention of CVD. Details of CVD events and risk factors included are listed in the methods. We will also determine any adverse events associated with taking fixed-dose combination therapy. This will include studies conducted in both developed and developing regions of the world.
authors.affiliation: Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
authors.forename: Angharad N
authors.initials: AN
authors.lastname: de Cates
authors.affiliation: Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
authors.forename: Matthew Rb
authors.initials: MR
authors.lastname: Farr
authors.affiliation: Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
authors.forename: Karen
authors.initials: K
authors.lastname: Rees
authors.affiliation: Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine; Department of Epidemiology and Public Health, University College London, London, UK.
authors.forename: Juan P
authors.initials: JP
authors.lastname: Casas
authors.affiliation: Departments of Preventative Medicine and Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Huffman